Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 26;3(3):pgae087.
doi: 10.1093/pnasnexus/pgae087. eCollection 2024 Mar.

Balancing the benefits of vaccination: An envy-free strategy

Affiliations

Balancing the benefits of vaccination: An envy-free strategy

Pedro Ribeiro de Almeida et al. PNAS Nexus. .

Abstract

The Covid-19 pandemic revealed the difficulties of vaccinating a population under the circumstances marked by urgency and limited availability of doses while balancing benefits associated with distinct guidelines satisfying specific ethical criteria. We offer a vaccination strategy that may be useful in this regard. It relies on the mathematical concept of envy-freeness. We consider finding balance by allocating the resource among individuals that seem heterogeneous concerning the direct and indirect benefits of vaccination, depending on age. The proposed strategy adapts a constructive approach in the literature based on Sperner's Lemma to point out an approximate division of doses guaranteeing that both benefits are optimized each time a batch becomes available. Applications using data about population age distributions from diverse countries suggest that, among other features, this strategy maintains the desired balance, throughout the entire vaccination period. We discuss complementary aspects of the method in the context of epidemiological models of age-stratified Susceptible - Infected - Recovered (SIR) type.

Keywords: balanced vaccine allocation; decision making process; direct and indirect benefits; envy-free division; pandemic preparedness.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
a) A defined partitioned simplex with d=7. The scheme is adapted from Ref. (10). Counselor CA chooses a side at all points A and counselor CB chooses a side at all points B. b) The traces of utility functions ( uA purple, uB green) are shown to illustrate the choice of CA, at an arbitrary point pi=2/7. c) Benefit evaluation on each side as the areas below the curves. d) Comparing benefits. e) Labeled simplex after both counselors, at each corresponding point, experience (b)–(d) and express their preferences for vaccinating on side I or on side II. In this example, the region shown defined by endpoints (pL,pR) encloses a point p* that sets an envy-free division of the simplex.
Fig. 2.
Fig. 2.
Illustrative example. Utility density functions uη(y), η=A,B evaluated from Eq. 1 for counselors CA (purple) and CB (green), respectively, with the continuous functions ρη(y) (supplementary material) built up using the four combinations of utilities in Table 1, for the population age groups of the United States.
Fig. 3.
Fig. 3.
Simulated time series for the benefits [2] acquired by each counselor, CA (orange) and CB (blue) through a) a random procedure and strategies, b) maximize-benefit, c) oldest-first, d) envy-free. The utility density functions employed correspond to the combination defined as Default in Fig. 2 and the results shown are for the population age distribution of the United States.
Fig. 4.
Fig. 4.
Time average of the differences (absolute values) [15] between the contributions of the two counselors to the benefits obtained through each strategy, extended to the population age groups of the selected countries, as specified. The utility density functions employed correspond to the combination defined as Default.
Fig. 5.
Fig. 5.
Simulated time series for the cumulative benefits Φη(t) [16] acquired by each counselor, CA (orange) and CB (blue) through a) a random procedure and strategies, b) maximize-benefit, c) oldest-first, d) envy-free. The utility density functions employed correspond to the combination defined as Default in Fig. 2. The results shown are for the population age distribution of the United States.
Fig. 6.
Fig. 6.
Time average of the differences (absolute values) ΔΦ¯ [18] between the contributions of the two counselors to the cumulative benefits obtained through each strategy, extended to the population age distributions of the selected countries, as specified. The utility density functions employed correspond to the combination defined as Default.
Fig. 7.
Fig. 7.
Time average of the mean cumulative benefit Φ¯ [19] between the contributions of the two counselors, for each strategy and selected countries. The utility density functions employed correspond to the combination defined as Default.
Fig. 8.
Fig. 8.
Time averages of a) the cumulative differences (absolute values) ΔΦ¯ [18], and b) the instantaneous differences (absolute values) ΔU¯ [15] against the mean Φ¯ [19], evaluated for the population age distributions of 236 selected countries for strategies and utility combinations, as indicated by colors. The distributions of the points are indicated by the lateral diagrams. Maximize-benefit (blue) minimize-benefit (green), oldest-first (brown), envy-free (red), and random procedure (orange).
Fig. 9.
Fig. 9.
The fraction of the doses to be allocated to each age group, at each time, to follow the envy-free strategy considering the different combinations of utilities, as indicated in Table 1. The results shown are for the population age distribution of the United States.

Similar articles

References

    1. World Health Organization . 2020. A global framework to ensure equitable and fair allocation of covid-19 products and potential implications for covid-19 vaccines. Technical Report, World Health Organization.
    1. National Academies of Sciences, Engineering, and Medicine . 2020. Framework for equitable allocation of COVID-19 vaccine. Washington (DC): The National Academies Press; doi:10.17226/25917. - DOI - PubMed
    1. Wu JH, John SD, Adashi EY. 2020. Allocating vaccines in a pandemic: the ethical dimension. Am J Med. 133(11):1241–1242. - PMC - PubMed
    1. Emanuel EJ, et al. 2020. An ethical framework for global vaccine allocation. Science. 369(6509):1309–1312. - PMC - PubMed
    1. Liu K, Chen Y, Lin R, Han K. 2020. Clinical features of covid-19 in elderly patients: a comparison with young and middle-aged patients. J Infect. 80(6):e14–e18. - PMC - PubMed